vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and JOINT Corp (JYNT). Click either name above to swap in a different company.
JOINT Corp is the larger business by last-quarter revenue ($15.2M vs $7.8M, roughly 1.9× CRYO CELL INTERNATIONAL INC). JOINT Corp runs the higher net margin — 6.5% vs -48.7%, a 55.2% gap on every dollar of revenue. On growth, JOINT Corp posted the faster year-over-year revenue change (3.1% vs -2.3%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $334.7K). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -28.6%).
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
The Joint Corp is a leading operator and franchisor of chiropractic care clinics primarily serving the U.S. market. It offers accessible, affordable routine chiropractic services, membership-based care plans, and caters to consumers seeking non-invasive musculoskeletal pain management and wellness support.
CCEL vs JYNT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.8M | $15.2M |
| Net Profit | $-3.8M | $991.1K |
| Gross Margin | 77.9% | 81.4% |
| Operating Margin | -50.6% | 4.9% |
| Net Margin | -48.7% | 6.5% |
| Revenue YoY | -2.3% | 3.1% |
| Net Profit YoY | -105.1% | 5510.5% |
| EPS (diluted) | $-0.46 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | $15.2M | ||
| Q3 25 | $7.8M | $13.4M | ||
| Q2 25 | $7.9M | $13.3M | ||
| Q1 25 | $8.0M | $13.1M | ||
| Q4 24 | $8.0M | $14.7M | ||
| Q3 24 | $8.1M | $30.2M | ||
| Q2 24 | $8.0M | $30.3M | ||
| Q1 24 | $7.9M | $29.7M |
| Q4 25 | $-3.8M | $991.1K | ||
| Q3 25 | $749.4K | $855.0K | ||
| Q2 25 | $355.8K | $93.4K | ||
| Q1 25 | $282.9K | $967.8K | ||
| Q4 24 | $-1.9M | $17.7K | ||
| Q3 24 | $1.1M | $-3.2M | ||
| Q2 24 | $655.8K | $-3.6M | ||
| Q1 24 | $556.2K | $947.0K |
| Q4 25 | 77.9% | 81.4% | ||
| Q3 25 | 77.0% | 80.1% | ||
| Q2 25 | 76.6% | 79.1% | ||
| Q1 25 | 75.1% | 77.3% | ||
| Q4 24 | 78.4% | 78.4% | ||
| Q3 24 | 73.6% | 90.7% | ||
| Q2 24 | 74.8% | 90.7% | ||
| Q1 24 | 73.7% | 90.9% |
| Q4 25 | -50.6% | 4.9% | ||
| Q3 25 | 24.3% | 1.2% | ||
| Q2 25 | 18.8% | -8.6% | ||
| Q1 25 | 13.3% | -5.2% | ||
| Q4 24 | -1.5% | 5.5% | ||
| Q3 24 | 17.2% | -1.6% | ||
| Q2 24 | 17.3% | -5.9% | ||
| Q1 24 | 10.5% | -1.4% |
| Q4 25 | -48.7% | 6.5% | ||
| Q3 25 | 9.6% | 6.4% | ||
| Q2 25 | 4.5% | 0.7% | ||
| Q1 25 | 3.5% | 7.4% | ||
| Q4 24 | -23.2% | 0.1% | ||
| Q3 24 | 13.0% | -10.5% | ||
| Q2 24 | 8.2% | -11.9% | ||
| Q1 24 | 7.1% | 3.2% |
| Q4 25 | $-0.46 | $0.06 | ||
| Q3 25 | $0.09 | $0.06 | ||
| Q2 25 | $0.04 | $0.01 | ||
| Q1 25 | $0.03 | $0.06 | ||
| Q4 24 | $-0.23 | $0.01 | ||
| Q3 24 | $0.13 | $-0.21 | ||
| Q2 24 | $0.08 | $-0.24 | ||
| Q1 24 | $0.07 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $23.6M |
| Total DebtLower is stronger | $8.4M | — |
| Stockholders' EquityBook value | $-18.6M | $15.1M |
| Total Assets | $61.7M | $61.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | $23.6M | ||
| Q3 25 | $3.2M | $29.7M | ||
| Q2 25 | $4.4M | $29.8M | ||
| Q1 25 | $3.5M | $21.9M | ||
| Q4 24 | $3.5M | $25.1M | ||
| Q3 24 | $2.1M | $20.7M | ||
| Q2 24 | $1.5M | $17.5M | ||
| Q1 24 | $979.6K | $18.7M |
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | $-18.6M | $15.1M | ||
| Q3 25 | $-14.8M | $22.7M | ||
| Q2 25 | $-15.6M | $23.2M | ||
| Q1 25 | $-14.7M | $22.8M | ||
| Q4 24 | $-13.2M | $20.7M | ||
| Q3 24 | $-9.6M | $20.5M | ||
| Q2 24 | $-10.7M | $23.2M | ||
| Q1 24 | $-10.3M | $26.2M |
| Q4 25 | $61.7M | $61.0M | ||
| Q3 25 | $63.2M | $69.4M | ||
| Q2 25 | $64.4M | $73.2M | ||
| Q1 25 | $64.4M | $80.1M | ||
| Q4 24 | $64.7M | $83.2M | ||
| Q3 24 | $62.9M | $79.6M | ||
| Q2 24 | $62.6M | $82.4M | ||
| Q1 24 | $61.7M | $85.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $1.8M |
| Free Cash FlowOCF − Capex | $1.2M | $334.7K |
| FCF MarginFCF / Revenue | 15.5% | 2.2% |
| Capex IntensityCapex / Revenue | 0.9% | 9.9% |
| Cash ConversionOCF / Net Profit | — | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $5.2M | $-1.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | $1.8M | ||
| Q3 25 | $2.5M | $1.8M | ||
| Q2 25 | $707.0K | $868.6K | ||
| Q1 25 | $954.1K | $-3.7M | ||
| Q4 24 | $2.2M | $9.4M | ||
| Q3 24 | $2.4M | $3.4M | ||
| Q2 24 | $1.8M | $-973.5K | ||
| Q1 24 | $-356.9K | $2.8M |
| Q4 25 | $1.2M | $334.7K | ||
| Q3 25 | $2.5M | $1.5M | ||
| Q2 25 | $644.6K | $363.6K | ||
| Q1 25 | $892.0K | $-4.0M | ||
| Q4 24 | $2.1M | $8.2M | ||
| Q3 24 | $2.3M | $3.2M | ||
| Q2 24 | $21.5K | $-1.2M | ||
| Q1 24 | $-814.6K | $2.4M |
| Q4 25 | 15.5% | 2.2% | ||
| Q3 25 | 31.9% | 10.9% | ||
| Q2 25 | 8.1% | 2.7% | ||
| Q1 25 | 11.2% | -30.8% | ||
| Q4 24 | 26.8% | 55.9% | ||
| Q3 24 | 27.9% | 10.6% | ||
| Q2 24 | 0.3% | -4.1% | ||
| Q1 24 | -10.4% | 8.1% |
| Q4 25 | 0.9% | 9.9% | ||
| Q3 25 | 0.5% | 2.4% | ||
| Q2 25 | 0.8% | 3.8% | ||
| Q1 25 | 0.8% | 2.5% | ||
| Q4 24 | 0.1% | 8.1% | ||
| Q3 24 | 2.3% | 0.8% | ||
| Q2 24 | 21.8% | 0.9% | ||
| Q1 24 | 5.8% | 1.3% |
| Q4 25 | — | 1.86× | ||
| Q3 25 | 3.38× | 2.07× | ||
| Q2 25 | 1.99× | 9.30× | ||
| Q1 25 | 3.37× | -3.82× | ||
| Q4 24 | — | 532.98× | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | — | ||
| Q1 24 | -0.64× | 2.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCEL
Segment breakdown not available.
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
